BR112013002702A2 - vacina - Google Patents

vacina

Info

Publication number
BR112013002702A2
BR112013002702A2 BR112013002702A BR112013002702A BR112013002702A2 BR 112013002702 A2 BR112013002702 A2 BR 112013002702A2 BR 112013002702 A BR112013002702 A BR 112013002702A BR 112013002702 A BR112013002702 A BR 112013002702A BR 112013002702 A2 BR112013002702 A2 BR 112013002702A2
Authority
BR
Brazil
Prior art keywords
vaccine
polypeptide
sequence
oarasite
apicomplex
Prior art date
Application number
BR112013002702A
Other languages
English (en)
Inventor
Smith Adrian
Blake Damer
Shirley Martin
Original Assignee
The Pirbright Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Pirbright Inst filed Critical The Pirbright Inst
Publication of BR112013002702A2 publication Critical patent/BR112013002702A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

vacina. a presente invenção proporciona um polipeptídeo compreendedno a sequência de aminoácidos como mostrado na seq id nº 1 ou um seu homólogo ou fragmento, um ácido nucleico capaz de codificar tal polipeptídeo e uma vacina compreendedno tal ácido peptídeo. a vacina pode ser utilizada para tratamento e/ou prevenção de uma doença associada com um oarasita apicomplexa.
BR112013002702A 2010-08-02 2011-08-02 vacina BR112013002702A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1013006.0A GB201013006D0 (en) 2010-08-02 2010-08-02 Vaccine
PCT/GB2011/051456 WO2012017230A1 (en) 2010-08-02 2011-08-02 Vaccine

Publications (1)

Publication Number Publication Date
BR112013002702A2 true BR112013002702A2 (pt) 2017-03-01

Family

ID=42799497

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013002702A BR112013002702A2 (pt) 2010-08-02 2011-08-02 vacina

Country Status (8)

Country Link
US (1) US20130216569A1 (pt)
EP (1) EP2601211B1 (pt)
CN (1) CN103201283A (pt)
BR (1) BR112013002702A2 (pt)
GB (1) GB201013006D0 (pt)
MX (1) MX2013001383A (pt)
RU (1) RU2013109278A (pt)
WO (1) WO2012017230A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000579B2 (en) 2018-01-12 2021-05-11 The United States Of America, As Represented By The Secretary Of Agriculture Recombinant Eimeria maxima protein delivered as nanoparticles
CN113289010A (zh) * 2021-05-30 2021-08-24 吉林大学 一种鸡球虫三价重组酵母亚单位疫苗及制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2158108T3 (es) * 1995-06-07 2001-09-01 Pfizer Vacunacion in ovo contra la coccidiosis.
DE602005003429T2 (de) * 2004-12-01 2008-10-02 Zeon Corp. Kodierende DNS für ein Eimeria Apical Membran Antigen 1 und dessen Verwendungen

Also Published As

Publication number Publication date
WO2012017230A1 (en) 2012-02-09
GB201013006D0 (en) 2010-09-15
RU2013109278A (ru) 2014-09-10
CN103201283A (zh) 2013-07-10
EP2601211B1 (en) 2017-10-11
US20130216569A1 (en) 2013-08-22
MX2013001383A (es) 2013-07-22
EP2601211A1 (en) 2013-06-12

Similar Documents

Publication Publication Date Title
CY1122178T1 (el) Πολυπεπτιδια
ECSP15042898A (es) Péptidos y composiciones para el tratamiento de daño articular
BR112017019625A2 (pt) udp-glicosiltransferases
SA518390954B1 (ar) لقاحات علاجية لفيروس الورم الحليمي البشري 18
EP2532365A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
AR093903A1 (es) Coagonistas de glucagon y glp-1 para el tratamiento de la obesidad
EP2532366A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT AND / OR PREVENTION OF CANCER
BR112014000466A2 (pt) polipeptídeos quiméricos e híbridos fator viii, métodos de uso dos mesmos
NZ602943A (en) Modified binding proteins inhibiting the vegf-a receptor interaction
IN2014DN05670A (pt)
GT201700224A (es) Proteína de unión a rgma y su uso
ES2531290T3 (es) Transferasas y oxidorreductasas, ácidos nucleicos que las codifican y métodos para prepararlas y usarlas
MX2014010664A (es) Identificacion de mutaciones de channelopsin-2 (chop2) y los metodos de uso.
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
EA201491277A1 (ru) Противораковый слитый белок
AR102410A1 (es) Polipéptidos que tienen actividad xilanasa con una tasa de conversión alta de polisacáridos que contienen xilosa
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
BR112017013453A2 (pt) novo peptídeo inibidor de pi3ky para o tratamento de doenças do sistema respiratório
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
BR112016011091A2 (pt) sequência de endolisina kz144 modificada
AR119056A2 (es) Péptido de fusión, polinucleótido que lo codifica, vector y célula transformada
BR112017014737A2 (pt) formulação de peptídeos inibidores de mk2
EA201391546A1 (ru) Противораковый слитый белок
BR112013002702A2 (pt) vacina
PE20121553A1 (es) Uso de una fuente de l3 y/o l5 como vacuna o como diagnostico para una efermedad parasitaria

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]